Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening-Reference-Cited by-同舟云学术

Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening

Published:2020-08 Issue: Volume:200 Page:112440
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Faïon Léo,Djaout Kamel,Frita Rosangela,Pintiala Catalin,Cantrelle Francois-Xavier,Moune Martin,Vandeputte Alexandre,Bourbiaux Kevin,Piveteau Catherine,Herledan Adrien,Biela Alexandre,Leroux Florence,Kremer Laurent,Blaise Mickael,Tanina Abdalkarim,Wintjens René,Hanoulle Xavier,Déprez Benoit,Willand Nicolas,Baulard Alain R.,Flipo Marion

Funder

Agence Nationale de la Recherche

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference58 articles.

1. Mechanism of thioamide drug action against tuberculosis and leprosy;Wang;J. Exp. Med.,2007

2. Advances in the development of new tuberculosis drugs and treatment regimens;Zumla;Nat. Rev. Drug Discov.,2013

3. Tuberculosis: the drug development pipeline at a glance;Villemagne;Eur. J. Med. Chem.,2012

4. FDA approval of bedaquiline — the benefit–risk balance for drug-resistant tuberculosis;Cox;N. Engl. J. Med.,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Mycobacterium tuberculosis Drug Resistance;Molecular Genetics, Microbiology and Virology;2024-03

2. Mycobacterium tuberculosis drugs resistance mechanisms;Molecular Genetics Microbiology and Virology (Russian version);2024

3. Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump;European Journal of Medicinal Chemistry;2023-11

4. Recent advances in Fragment-based strategies against tuberculosis;European Journal of Medicinal Chemistry;2023-10

5. Designing New Magic Bullets to Penetrate the Mycobacterial Shield: An Arduous Quest for Promising Therapeutic Candidates;Microbial Drug Resistance;2023-05-01